Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter ...

Overview: Strong knowledge of data structures and recognizing common patterns makes complex coding questions easier and faster to solve.Thinking out loud during ...

Guidance extended from year-end 2027 to early 2028, with operating expense reduction targets reiterated and achieved at a greater scale (now 35% year-over-year, 10% below guidance). Strategic focus ...

Apheris's ADMET Network will combine proprietary datasets in a privacy-preserving environment to accelerate AI drug discovery models.

Totaligent (OTCID: TGNT) announced the execution of a binding Letter of Intent (LOI) with GloMed Solutions Limited Liability Company, a Japanese medical aesthetics and biologics distributor, to form a ...

LinkDaddy announces the launch of a patent-compliant website infrastructure service, delivering four-patent-compliant builds ...

Vitalik Buterin Unveils Ethereum Quantum-Resistance Roadmap. Vitalik Buterin has outlined a four-pronged plan to harden Ethereum against quantum threats, identifying four areas most vulnerable: ...

AI development is often framed as a race among countries, companies and academic researchers. But figuring out who’s actually ...

BTDUex cryptocurrency exchange, a global leader in intelligent finance, today officially announced the launch of its 2026 flagship strategic initiative: a global smart trading competition with a ...

Midnight ($NIGHT) secures Google Cloud and MoneyGram as node operators ahead of its Kukolu mainnet launch, expected late ...